↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Tyck till om SwePub Sök här!

Träfflista för sökning "WFRF:(Oranje B) srt2:(2015-2019)"

Sökning: WFRF:(Oranje B) > (2015-2019)

Resultat 1-4 av 4

Sortera/gruppera träfflistan

Sortering: Träffar per sida:

Numrering	Referens	Omslagsbild	Hitta
1.	Oldehinkel, M, et al. (författare) Altered Connectivity Between Cerebellum, Visual, and Sensory-Motor Networks in Autism Spectrum Disorder: Results from the EU-AIMS Longitudinal European Autism Project 2019 Ingår i: Biological psychiatry. Cognitive neuroscience and neuroimaging. - : Elsevier BV. - 2451-9030 .- 2451-9022. ; 4:3, s. 260-270 Tidskriftsartikel (refereegranskat)
2.	Tillmann, J, et al. (författare) Investigating the factors underlying adaptive functioning in autism in the EU-AIMS Longitudinal European Autism Project 2019 Ingår i: Autism research : official journal of the International Society for Autism Research. - : Wiley. - 1939-3806. ; 12:4, s. 645-657 Tidskriftsartikel (refereegranskat)
3.	Wedgeworth, E, et al. (författare) Propranolol in the treatment of infantile haemangiomas: Lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce Survey. 2015 Ingår i: British Journal of Dermatology. - : Oxford University Press (OUP). - 1365-2133 .- 0007-0963. Tidskriftsartikel (refereegranskat)abstract Oral propranolol is widely prescribed as first line treatment for infantile haemangiomas (IHs) and anecdotally prescribing practice differs widely between centres.
4.	Wollenberg, A., et al. (författare) ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients 2016 Ingår i: Journal of the European Academy of Dermatology and Venereology. - : Wiley. - 0926-9959. ; 30:5, s. 729-747 Tidskriftsartikel (refereegranskat)abstract Atopic dermatitis (AD) is a clinically defined, highly pruritic, chronic inflammatory skin disease of children and adults. The diagnosis is made using evaluated clinical criteria. Disease activity is best measured with a composite score assessing both objective signs and subjective symptoms, such as SCORAD. The management of AD must consider the clinical and pathogenic variabilities of the disease and also target flare prevention. Basic therapy includes hydrating topical treatment, as well as avoidance of specific and unspecific provocation factors. Anti-inflammatory treatment of visible skin lesions is based on topical glucocorticosteroids and the topical calcineurin inhibitors tacrolimus and pimecrolimus. Topical calcineurin inhibitors are preferred in sensitive locations. Tacrolimus and mid-potent steroids are proven for proactive therapy, which is long-term intermittent anti-inflammatory therapy of the frequently relapsing skin areas. Systemic anti-inflammatory or immunosuppressive treatment is indicated for severe refractory cases. Biologicals targeting key mechanisms of the atopic immune response are promising emerging treatment options. Microbial colonization and superinfection may induce disease exacerbation and can justify additional antimicrobial treatment. Systemic antihistamines (H1R-blockers) may diminish pruritus, but do not have sufficient effect on lesions. Adjuvant therapy includes UV irradiation, preferably UVA1 or narrow-band UVB 311 nm. Dietary recommendations should be patient specific and elimination diets should only be advised in case of proven food allergy. Allergen-specific immunotherapy to aeroallergens may be useful in selected cases. Psychosomatic counselling is recommended to address stress-induced exacerbations. 'Eczema school' educational programmes have been proven to be helpful for children and adults.

Skapa referenser, mejla, bekava och länka

Länka till träfflistan

Resultat 1-4 av 4

Avgränsa träffmängd

Typ av publikation: tidskriftsartikel (4)

Typ av innehåll: refereegranskat (4)

Författare/redaktör: Dell'Acqua, F (3); Holt, R. (2); Bolte, S (2); Toro, R (2); Zwiers, MP (2); Buitelaar, JK (2); visa fler...; Meyer-Lindenberg, A (2); Williams, SCR (2); Sacco, R. (2); Bourgeron, T. (2); Banaschewski, T. (2); Ruggeri, B (2); Frouin, V (2); Baumeister, S (2); Moessnang, C (2); Tillmann, J (2); Goyard, D (2); Charman, T (2); Ambrosino, S (2); Baron-Cohen, S (2); Crawley, D (2); Dumas, G (2); Durston, S (2); Ecker, C (2); Hayward, H (2); Johnson, MH (2); Jones, EJH (2); Lai, MC (2); Mason, L (2); Oakley, B (2); Oldehinkel, M (2); Persico, AM (2); Loth, E (2); Tost, H (2); Brandeis, D (2); Caceres, AS (2); Ahmad, J (2); Auyeung, B (2); Bours, C (2); Brammer, M (2); Brogna, C (2); de Bruijn, Y (2); Chakrabarti, B (2); Cornelissen, I (2); Faulkner, J (2); Garces, P (2); Ham, L (2); Hipp, J (2); Kundu, P (2); D'Ardhuy, XL (2); visa färre...

Lärosäte: Karolinska Institutet (3); Lunds universitet (2)

Språk: Engelska (4)

Forskningsämne (UKÄ/SCB): Medicin och hälsovetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - Nationella bibliotekssystem
LIBRIS.kb.se

pil uppåt

Stäng

Kopiera och spara länken för att återkomma till aktuell vy